An Engineered Cytidine Deaminase for Biocatalytic Production of a Key Intermediate of the Covid-19 Antiviral Molnupiravir. (2022)
Attributed to:
A versatile biocatalytic platform for scalable therapeutic oligonucleotide manufacturing
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/jacs.1c11048
PubMed Identifier: 35224970
Publication URI: http://europepmc.org/abstract/MED/35224970
Type: Journal Article/Review
Volume: 144
Parent Publication: Journal of the American Chemical Society
Issue: 9
ISSN: 0002-7863